EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H13ClN2O4 |
| Net Charge | 0 |
| Average Mass | 344.754 |
| Monoisotopic Mass | 344.05638 |
| SMILES | Cc1ccc(C=C2C(=O)NC(=O)N(Cc3ccccc3Cl)C2=O)o1 |
| InChI | InChI=1S/C17H13ClN2O4/c1-10-6-7-12(24-10)8-13-15(21)19-17(23)20(16(13)22)9-11-4-2-3-5-14(11)18/h2-8H,9H2,1H3,(H,19,21,23) |
| InChIKey | QLYYBGQYQIWCTK-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 1-[(2-chlorophenyl)methyl]-5-[(5-methyl-2-furanyl)methylidene]-1,3-diazinane-2,4,6-trione (CHEBI:109393) is a barbiturates (CHEBI:22693) |
| Manual Xrefs | Databases |
|---|---|
| LSM-20791 | LINCS |